Survivin Delta Ex3 Overexpression in Thyroid Malignancies-Reference-Cited by-同舟云学术

Survivin Delta Ex3 Overexpression in Thyroid Malignancies

Published:2014-06-19 Issue:6 Volume:9 Page:e100534
ISSN:1932-6203
Container-title:PLoS ONE
language:en
Short-container-title:PLoS ONE

Author:

Waligórska-Stachura Joanna,Andrusiewicz Mirosław,Sawicka-Gutaj Nadia,Biczysko Maciej,Jankowska Anna,Kubiczak Marta,Czarnywojtek Agata,Wrotkowska Elżbieta,Ruchała Marek

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference30 articles.

1. New insights in thyroid follicular cell biology and its impact in thyroid cancer therapy;G Riesco-Eizaguirre;Endocr Relat Cancer,2007

2. Prognostic factors and therapetic strategies for differentiated carcinomas of the thyroid;Y Miyauchi Ito;Endocr J,2009

3. BRAF mutation in thyroid cancer;M Xing;Endocr Relat Cancer,2005

4. Profile of cabozantinib and its potential in the treatment of advanced medullary thyroid cancer;CD Hart;Onco Targets,2013

5. Evaluation of survivin expression and its prognostic value in papillary thyroid carcinoma;S Selemetjev;Pathol Res Pract,2014

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Survivin as a diagnostic and therapeutic marker for thyroid cancer;Pathology - Research and Practice;2019-04

2. Overexpression of nicotinamide N-methyltransferase in HSC-2 OSCC cell line: effect on apoptosis and cell proliferation;Clinical Oral Investigations;2018-06-07

3. The association between irisin and muscle metabolism in different thyroid disorders;Clinical Endocrinology;2017-12-20

4. Immune responses in the thyroid cancer microenvironment: making immunotherapy a possible mission;Endocrine-Related Cancer;2017-12

5. Survivin and XIAP – two potential biological targets in follicular thyroid carcinoma;Scientific Reports;2017-09-12